Enanta Pharmaceuticals, Inc. is a biotechnology company based in Watertown, MA, specializing in the discovery and development of antiviral compounds. The company focuses on innovative therapies targeting viral infections, particularly in the areas of hepatitis B and respiratory syncytial virus (RSV). Enanta's research encompasses a range of core technologies, including heterocyclic agents and functionalized heterocycles, aimed at regulating apoptosis and developing effective treatments for viral diseases.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 6 2026

299 Patents

#2 in Watertown, MA

#84 in Massachusetts

#1,466 in US

#2,987 in the World

Watertown, MA, United States of America

Enanta Pharmaceuticals, Inc.

Forward Citations = 1,849

123 inventors:

Yat Sun Or (297 out of 349 patents)

Guoqiang Wang (110 out of 113 patents)

Yao-Ling Qiu (75 out of 75 patents)

4. Xiaowen Peng (65 out of 65 patents)

5. Zhe Wang (60 out of 74 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Enanta Pharmaceuticals, Inc.. Retrieved from https://idiyas.com/company/enanta-pharmaceuticals

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

5 patents (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

26 patents (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]